Indian CROs Move Up R&D Value Chain From Outsourcing Services To Partnering With MNCs
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India, along with China, is increasingly becoming a popular destination for pharmaceutical research and development outsourced from the West, and more multinational companies are partnering with Indian CROs to improve productivity, cut costs and bring more drugs to market faster